Tonsillectomy Clinical Trial
Official title:
SNAKES UK: a Pilot Trial of Jelly Snakes to Prevent Postoperative Nausea and Vomiting in Kids After ENT Surgery
Postoperative nausea and vomiting in children is a common phenomenon, particularly after ear
nose and throat (ENT) surgery. While it affects up to 80% of patients who do not receive
preventative medication during their operation, more than 1 in 5 children still suffer from
postoperative nausea and vomiting after tonsillectomy even when given 2 medications to
prevent it. Nausea and vomiting after an operation (postoperatively) particularly following
tonsillectomy can be very painful and distressing for the child and their carer. Vomiting may
also increase the risk of postoperative bleeding, a serious complication after the surgery.
Postoperative nausea and vomiting is not only one of the main reasons for prolonged hospital
stay or re-admission in children; it is also one of the main reasons for dissatisfaction with
anaesthesia in children and their families. In adults, a pilot study has found that chewing
gum postoperatively can significantly reduce postoperative nausea and vomiting. Chewing and
swallowing, results in increased activity in the gut and lessens the effects of medications
given under anaesthesia that tend to slow the gut.
However, for young children particularly following anaesthesia, chewing gum may not be a safe
option. Therefore, in this pilot study the investigators will investigate if chewing a large
jelly confectionary snake after the anaesthetic will help to reduce nausea and vomiting. The
children who are enrolled in the study will be randomised to receive a jelly snake or no
jelly snake to chew once awake after the surgery. There will be no other changes to the
standard management which will be in accordance to institutional guidelines. The
investigators will then compare the rates of vomiting between the children who did and did
not receive a jelly snake to chew. We will also monitor other oral and food intake and
requirements for painkillers, as well as for other potential problems (e.g. delayed
discharge) after surgery.
The advantage of using a jelly snake is that it is a simple, inexpensive, non-drug treatment.
Parents are very keen to avoid the use of drugs for their children and so would be open to
the use of this new approach. For children the jelly snake offers something familiar and an
enjoyable solution to their discomfort. The use of jelly snakes could also be a simple
intervention that parents could do at home following day case surgery for other procedures.
While the jelly snakes are high in sugar, they are comparable to the sugar content of a glass
of fruit juice, flavoured milk or soft drinks. Generally, in the investigators' experience,
the willingness of parents to allow their children to receive treats in the postoperative
period is very high, particularly since all children have a significant time of fasting (at
least 6 hours, often longer) for solid foods prior to surgery.
Status | Not yet recruiting |
Enrollment | 240 |
Est. completion date | April 2020 |
Est. primary completion date | April 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Years to 16 Years |
Eligibility |
Inclusion Criteria: - Volatile anaesthetic-based general anaesthesia - Written informed parental consent - Elective tonsillectomy +/- adenoidectomy (+/- myringotomy, EUA ear, grommets or cautery of inferior turbinates') Exclusion Criteria: - Plan to use muscle relaxant - Plan to use topical lignocaine on the vocal cords intraoperatively - Contraindication to chewy jelly snakes or any of their components e.g. known allergy to any of the ingredients of the chewy jelly snakes or impaired pharyngeal/oesophageal function (e.g. bulbar palsy, achalasia), children with diabetes and vegetarian children - Contraindication to any protocolised anti-emetic drug (prophylaxis, intervention or rescue) - Parents/guardians or children who, in the opinion of the investigator, may be unable to understand or give informed consent will be excluded from the study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Prof. Thomas Engelhardt |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of postoperative vomiting in paediatric patients in the first 6 hours after volatile anaesthetic-based general anaesthesia for adenoidectomies and / or tonsillectomies | up to 6 hours after the end of the surgery | ||
Secondary | Incidence of nausea in the first 6 hours post tonsillectomy +/- adenoidectomy surgery in children over 8 years | up to 6 hours after the surgery | ||
Secondary | • Number of rescue treatments for PONV in the first 6 hours | up to 6 hours after the surgery | ||
Secondary | • Incidence of PONV in the first 24 hours or up until discharge (whatever occurs first) | Up to 24 hours | ||
Secondary | • Time to first vomit if applicable (measured from arrival in PACU) | Up to 24 hours | ||
Secondary | • Time to first meal | Up to 24 hours | ||
Secondary | • Duration of hospital stay | Up to 48 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03266094 -
A Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy
|
N/A | |
Completed |
NCT02228135 -
The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage
|
N/A | |
Completed |
NCT00662987 -
Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy
|
N/A | |
Completed |
NCT00273754 -
The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
|
Phase 2 | |
Recruiting |
NCT06122948 -
Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events
|
Phase 3 | |
Recruiting |
NCT03783182 -
Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy
|
Phase 4 | |
Completed |
NCT03793816 -
Tonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial
|
N/A | |
Not yet recruiting |
NCT06359925 -
Suprazygomatic Nerve Block in Tonsillectomy Patients
|
N/A | |
Recruiting |
NCT06079125 -
PFDD Versus PFDRT in Chiari Decompression Surgery
|
N/A | |
Recruiting |
NCT01904461 -
HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children
|
N/A | |
Not yet recruiting |
NCT00756873 -
Etoricoxib in Ear Nose Throat Surgery
|
Phase 3 | |
Recruiting |
NCT05600595 -
The Evaluation of Eustachian Tube Function and Its Influencing Factors After Snoring Operation in Children
|
||
Completed |
NCT02987985 -
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
|
Phase 3 | |
Completed |
NCT04066829 -
Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy
|
N/A | |
Recruiting |
NCT05158348 -
A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine
|
Phase 3 | |
Completed |
NCT01605903 -
Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy
|
Phase 2 | |
Enrolling by invitation |
NCT02444533 -
EXPAREL® for Pain After Tonsillectomy
|
Phase 4 | |
Recruiting |
NCT02829515 -
Tonsil Surgery in Sweden: A National Quality Register
|
||
Not yet recruiting |
NCT03491085 -
Role of Antibiotics Post Tonsillectomy
|
Phase 1/Phase 2 | |
Recruiting |
NCT05270109 -
Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity
|
N/A |